Medicaments for the treatment or prevention of fibrotic diseases

US10154990B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• John Park · Warthausen, DE
• Gerald Juergen Roth · Biberach, DE
• Armin Heckel · Biberach an der Riß, DE
• Nveed Chaudhary · Southampton, GB
• Trixi Brandl · Warthausen, DE
• Georg Dahmann · Biberach an der Riß, DE
• Matthias Grauert · Ingelheim am Rhein, DE

Key dates

• Filing date: Dec 29, 2015
• Grant date: Dec 18, 2018
• Expiry date: Jan 17, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/0019
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of indolinones of general formula